QRG Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $697K | Buy |
2,136
+187
| +10% | +$61K | 0.01% | 715 |
|
|
2025
Q1 | $526K | Buy |
1,949
+964
| +98% | +$260K | 0.01% | 753 |
|
|
2024
Q4 | $232K | Buy |
985
+180
| +22% | +$42.4K | ﹤0.01% | 993 |
|
|
2024
Q3 | $221K | Buy |
+805
| New | +$221K | ﹤0.01% | 1009 |
|
|
2024
Q1 | – | Sell |
-1,101
| Closed | -$211K | – | 1062 |
|
|
2023
Q4 | $211K | Buy |
+1,101
| New | +$211K | ﹤0.01% | 973 |
|